| P50 | author | Helen Hobbs | Q21433424 |
| | Jonathan C. Cohen | Q24063837 |
| | Jay D Horton | Q89378224 |
| P2093 | author name string | Zhenze Zhao | |
| | Lisa Kinch | |
| | Thomas A Lagace | |
| | Yetsa Tuakli-Wosornu | |
| | Nicholas V Grishin | |
| P2860 | cites work | The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation | Q24293346 |
| | Functional characterization of Narc 1, a novel proteinase related to proteinase K | Q24299854 |
| | Gapped BLAST and PSI-BLAST: a new generation of protein database search programs | Q24545170 |
| | Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype | Q24563948 |
| | Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes | Q24683425 |
| | Crystal structure of fervidolysin from Fervidobacterium pennivorans, a keratinolytic enzyme related to subtilisin | Q27642831 |
| | Further additions to MolScript version 1.4, including reading and contouring of electron-density maps | Q27860974 |
| | Mutations in PCSK9 cause autosomal dominant hypercholesterolemia | Q28202519 |
| | Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells | Q28585300 |
| | Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9 | Q28588292 |
| | Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics | Q29616134 |
| | Sequence variations in PCSK9, low LDL, and protection against coronary heart disease | Q29616310 |
| | Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment | Q33767310 |
| | The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1. | Q33921616 |
| | Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice | Q34219528 |
| | Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9. | Q34323329 |
| | NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol | Q34347298 |
| | Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. | Q34385127 |
| | A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. | Q34399014 |
| | Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia | Q34403629 |
| | Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. | Q38336252 |
| | Effect of mutations in the PCSK9 gene on the cell surface LDL receptors | Q40298570 |
| | Detecting distant homology with Meta-BASIC. | Q41010576 |
| | Low density lipoprotein receptor-related protein mediates endocytosis of monoclonal antibodies in cultured cells and rabbit liver. | Q41212549 |
| | Missense mutations in ABCG5 and ABCG8 disrupt heterodimerization and trafficking | Q44822080 |
| | Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy | Q46902329 |
| | The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. | Q51529673 |
| | Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B | Q61971392 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 514-523 | |
| P577 | publication date | 2006-07-18 | |
| P1433 | published in | American Journal of Human Genetics | Q4744249 |
| P1476 | title | Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote | |
| P478 | volume | 79 | |